First-Ever Point-Of-Care COVID-19 Serology Test Granted EUA By FDA

The US agency on 23 September granted emergency use authorization for the Assure COVID-19 IgG/IgM Rapid Test Device to be used in point-of-care settings like doctor’s offices, hospitals, urgent care centers and emergency rooms. The test requires a fingerstick to draw blood.

Health Screenings: Fingerstick or Venous Blood Draw for Laboratory Hematology
The Assure POC test requires a fingerstick to draw blood

More from Diagnostics

More from Device Area